Companies House · 02372699

OCTAPHARMA LIMITED

UK registered company, private limited company, incorporated 17 Apr 1989.

Active
44
Public contracts
0
Spend payments
Total spend

OCTAPHARMA LIMITED is a UK company registered at Companies House under number 02372699. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
02372699
Status
Active
Company type
Private Limited Company
Incorporated
17 Apr 1989
Country of origin
United Kingdom
Registered office
GLASSWORKS HOUSE, MANCHESTER, M4 1EZ, ENGLAND
Nature of business (SIC)
21100 - Manufacture of basic pharmaceutical products
Accounts category
FULL
View source on data.gov.uk

Public sector contracts

Contract awards linked to OCTAPHARMA LIMITED.

ProcurementBuyerAwardedValue
NP31518 Albumin ProductsThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England
NHS Framework Agreement for the supply of Human AlbuminThe NHS Commissioning Board (operating under the name of NHS England)
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia BNHS England
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia BNHS England
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia BNHS England
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia BNHS England
Human Derived Blood ProductsNHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinNHS England
NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinNHS England
NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinNHS England
NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinNHS England
NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga)The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D ImmunoglobulinThe NHS Commissioning Board (operating under the name of NHS England)
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D ImmunoglobulinThe NHS Commissioning Board (operating under the name of NHS England)
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D ImmunoglobulinThe NHS Commissioning Board (operating under the name of NHS England)
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D ImmunoglobulinThe NHS Commissioning Board (operating under the name of NHS England)
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D ImmunoglobulinThe NHS Commissioning Board (operating under the name of NHS England)
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D ImmunoglobulinThe NHS Commissioning Board (operating under the name of NHS England)
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England
Octapharma - Blood Disorder Treatment products (inc Haemophilia A & B)Norfolk and Norwich University Hospitals NHS Foundation Trust1 Jan 2025£71.6k
NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinNHS England19 Dec 2024£905.2m
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England30 May 2024£765m
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England30 May 2024£765m
Octapharma Ltd - Octaplas LGNorfolk and Norwich University Hospitals NHS Foundation Trust29 Apr 2023£52.5k
Blood product required for the treatment of TTP patientsUniversity Hospitals of Leicester NHS Trust1 Aug 2022£97.5k
Octaplex TreatmentCalderdale and Huddersfield NHS Foundati30 Jun 2022£100k
Bleeding Disorders including Haemophilia BNHS England14 Jun 2022£250m
Bleeding Disorders including Haemophilia BNHS England14 Jun 2022£250m
Human Normal Immunoglobulin and Anti-D ImmunoglobulinNHS England22 Jun 2021£450m
NHS NATIONAL FRAMEWORK AGREEMENT AGREEMENT FOR HUMAN ALBUMIN SOLUTION (HAS)HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST25 Apr 2021£222.9k
Human AlbuminNHS England18 Mar 2021£26.4m
Supply of coagulopathy productsBIRMINGHAM WOMENS AND CHILDRENS NHS FOUNDATION TRUST23 Feb 2021£200k
NHS National Framework Agreement for the supply of products for the treatment of Haemophilia ANHS England2 Jun 2020£334.4m
SD PlasmaBIRMINGHAM CHILDREN'S HOSPITAL NHS FOUNDATION TRUST5 Mar 2019£200k
NHS Framework - products for the treatment of Bleeding DisordersNHS England19 Jun 2018£360m
Albumin and Anti-D ImmunoglobulinHull & East Yorkshire Hospitals Nhs Trust29 Apr 2018£225k
Solvent Detergent Treated FFPBIRMINGHAM CHILDRENS HOSPITAL6 Mar 2018£175.3k
NHS Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disordersNHS England24 Nov 2017£302m
OctaplasBIRMINGHAM CHILDRENS HOSPITAL24 Mar 2017£175.3k
Octaplas LGBIRMINGHAM CHILDRENS HOSPITAL1 Mar 2016£149.8k

Supplier identities

How this company appears as a supplier across the data.

FAQs about OCTAPHARMA LIMITED

Is OCTAPHARMA LIMITED an active company?

OCTAPHARMA LIMITED (company number 02372699) is recorded as "Active", incorporated on 17 Apr 1989.

What does OCTAPHARMA LIMITED do?

Its Companies House nature-of-business (SIC) is: 21100 - Manufacture of basic pharmaceutical products.

Has OCTAPHARMA LIMITED won UK public-sector contracts?

Yes — 44 public-sector contract awards are linked to this company in our data.

Where is OCTAPHARMA LIMITED based?

Its registered office is GLASSWORKS HOUSE, MANCHESTER, M4 1EZ, ENGLAND.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable